U.S. Patent 7963963 was awarded to Medtronic, Inc. on 2011-06-21 and describes a “Electrosurgical hemostat.” This patent has been cited 300 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

A hemostat-type device for ablative treatment of tissue, particularly for treatment of atrial fibrillation, is constructed with features that provide easy and effective treatment. The device may include a swiveling head assembly that allows the jaws to be adjusted in pitch and/or roll. The device may include a malleable or articulating handle shaft, as well as, malleable or curved rigid jaws that can permit curved lesion shapes. A locking detent can secure the jaws in a closed position during the procedure. The device may include one or more remote actuators making the hemostat-type device useful for minimally invasive procedures. Link: U.S. Patent 7963963

This patent was originally filed on 2005-01-21 which gives it a processing time of 2342 days, compared to an average processing time of 1942 in the field. Medtronic, Inc. has 6737 total patents. The first named inventor is Steven C. Christian of Brighton, MI. The primary examiner was Michael Peffley.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/